当前位置：
X-MOL 学术
›
Curr Comput Aided Drug Des
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Mechanisms of Compound Sophora flavescens (Kushen) Decoction for the Treatment of Ulcerative Colitis based on Network Pharmacology and Molecular Docking Technology.
Current computer-aided drug design Pub Date : 2022-01-01 , DOI: 10.2174/1573409918666220406103708 Zijing Peng 1, 2 , Zhuoling Zheng 1 , Min Gao 1 , Li Qin 1 , Lixiong Xiong 1 , Xiaoyan Li 1 , Jingwen Xie 1
Current computer-aided drug design Pub Date : 2022-01-01 , DOI: 10.2174/1573409918666220406103708 Zijing Peng 1, 2 , Zhuoling Zheng 1 , Min Gao 1 , Li Qin 1 , Lixiong Xiong 1 , Xiaoyan Li 1 , Jingwen Xie 1
Affiliation
BACKGROUND
The compound Sophora flavescenes (Kushen) decoction was found to reduce the inflammatory symptom of Ulcerative Colitis (UC). However, there exists a very limited understanding of the molecular pharmacological mechanisms.
OBJECTIVE
This study aimed to explore the mechanism of compound Sophora flavescens (Kushen) decoction in treating ulcerative colitis from the perspective of network pharmacology.
METHODS
Active components and potential targets of compound Sophora flavescens (Kushen) decoction were obtained through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database. GeneCards and other databases were used to predict and screen ulcerative colitis-related genes. Cytoscape software was applied to construct the "drugactive component-disease-target" network. GO function and KEGG pathway enrichment analyses revealed the potential pathway of the compound Sophora flavescenes (Kushen) decoction for UC.
RESULTS
After the screening, a total of 124 active ingredients and 163 potential therapeutic targets for UC were obtained from the compound Sophora flavescens (Kushen) decoction. Protein interaction network analysis showed that 15 key targets could be identified for the possible treatment of UC. GO and KEGG analyses showed that the active ingredients in the compound Sophora flavescens (Kushen) decoction were mainly enriched in 2556 biological processes and 172 signaling pathways.
CONCLUSION
The study showed that the compound Sophora flavescens (Kushen) decoction has therapeutic effects on UC through multi-component, multi-target, and multi-pathway.
中文翻译：
基于网络药理学和分子对接技术的复方苦参汤治疗溃疡性结肠炎的作用机制。
背景技术研究发现复方苦参汤可减轻溃疡性结肠炎（UC）的炎症症状。然而，对分子药理机制的了解非常有限。目的从网络药理学的角度探讨复方苦参汤治疗溃疡性结肠炎的作用机制。方法通过中药系统药理数据库和分析平台（TCMSP）数据库获取复方苦参汤的活性成分和潜在靶点。GeneCards 和其他数据库用于预测和筛选溃疡性结肠炎相关基因。应用Cytoscape软件构建“药物活性成分-疾病-靶点”网络。GO功能和KEGG通路富集分析揭示了复方苦参汤治疗UC的潜在通路。结果经筛选，复方苦参汤共获得124个有效成分和163个潜在的UC治疗靶点。蛋白质相互作用网络分析表明，可以确定 15 个可能治疗 UC 的关键靶点。GO和KEGG分析表明，复方苦参汤中的活性成分主要富集在2556个生物过程和172个信号通路中。结论 研究表明，复方苦参汤对UC具有多成分、多靶点、多途径的治疗作用。
更新日期：2022-04-06
中文翻译：
基于网络药理学和分子对接技术的复方苦参汤治疗溃疡性结肠炎的作用机制。
背景技术研究发现复方苦参汤可减轻溃疡性结肠炎（UC）的炎症症状。然而，对分子药理机制的了解非常有限。目的从网络药理学的角度探讨复方苦参汤治疗溃疡性结肠炎的作用机制。方法通过中药系统药理数据库和分析平台（TCMSP）数据库获取复方苦参汤的活性成分和潜在靶点。GeneCards 和其他数据库用于预测和筛选溃疡性结肠炎相关基因。应用Cytoscape软件构建“药物活性成分-疾病-靶点”网络。GO功能和KEGG通路富集分析揭示了复方苦参汤治疗UC的潜在通路。结果经筛选，复方苦参汤共获得124个有效成分和163个潜在的UC治疗靶点。蛋白质相互作用网络分析表明，可以确定 15 个可能治疗 UC 的关键靶点。GO和KEGG分析表明，复方苦参汤中的活性成分主要富集在2556个生物过程和172个信号通路中。结论 研究表明，复方苦参汤对UC具有多成分、多靶点、多途径的治疗作用。
京公网安备 11010802027423号